New Leaf Venture Partners’s Wave Life Sciences WVE Stock Holding History

New Leaf Venture Partners’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-425,429	Closed	-$17.9M	–	24
2018 Q4	$17.9M	Hold	425,429	–	–	4.91%	6
2018 Q3	$21.3M	Sell	425,429 -8,000	-2%	-$361K	3.87%	6
2018 Q2	$16.6M	Sell	433,429 -24,830	-5%	-$1.07M	4%	6
2018 Q1	$18.4M	Hold	458,259	–	–	9.92%	3
2017 Q4	$16.1M	Sell	458,259 -200,000	-30%	-$5.83M	7.52%	4
2017 Q3	$14.3M	Hold	658,259	–	–	6.64%	5
2017 Q2	$12.2M	Hold	658,259	–	–	8.6%	5
2017 Q1	$18.1M	Hold	658,259	–	–	9.27%	4
2016 Q4	$17.2M	Sell	658,259 -125,900	-16%	-$4.1M	12.33%	4
2016 Q3	$25.5M	Hold	784,159	–	–	18.33%	1
2016 Q2	$16.2M	Hold	784,159	–	–	13.96%	3
2016 Q1	$10.9M	Hold	784,159	–	–	9.85%	5
2015 Q4	$12.5M	Buy	+784,159	New	+$12.3M	8.37%	7

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

New Leaf Venture Partners's WVE Position: Q1 2019 in Review

New Leaf Venture Partners sold out of Wave Life Sciences (WVE) in Q1 2019, closing a stake of 425,429 shares — an estimated $17.9M sold.

New Leaf Venture Partners first reported a position in WVE in Q4 2015 and held it in 13 quarters. The position peaked at $25.5M in Q3 2016. 110 funds tracked by Wall St. Rank hold WVE as of Q1 2019.

New Leaf Venture Partners reported no remaining Wave Life Sciences position as of Q1 2019 after selling out during the quarter.
New Leaf Venture Partners sold 425,429 Wave Life Sciences shares in Q1 2019, an estimated $17.9M.
New Leaf Venture Partners first reported a position in Wave Life Sciences in Q4 2015 and held it in 13 quarters.
New Leaf Venture Partners's Wave Life Sciences position peaked at $25.5M in Q3 2016.
110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2019.

Based on New Leaf Venture Partners's 13F filing for Q1 2019, filed 15 May 2019.